Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 6/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | MIF | P14174 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10060202 | 1.00 | CYP2C9 (0.42) | CYP2C9ALDH1A1LMNASMN1; SMN2ATM | |
| SCHEMBL10060203 | 1.00 | CYP2C9 (0.42) | CYP2C9ALDH1A1LMNASMN1; SMN2ATM | |
| SCHEMBL18133559 | 0.87 | CYP2C9 (0.38) | CYP2C9ALDH1A1LMNA | |
| SCHEMBL14407409 | 0.86 | ALDH1A1 (0.32) | CYP2C9ALDH1A1LMNASMN1; SMN2ATM | |
| SCHEMBL12866132 | 0.83 | CYP2C9 (0.44) | CYP2C9ALDH1A1LMNAPOLBMEN1 | |
| SCHEMBL17695636 | 0.80 | CYP2C9 (0.42) | CYP2C9ALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL18098123 | 0.80 | CYP2C9 (0.40) | CYP2C9ALDH1A1LMNAHSD17B10 | |
| SCHEMBL13948387 | 0.78 | CYP2C9 (0.36) | CYP2C9ALDH1A1LMNASMN1; SMN2NPSR1 | |
| SCHEMBL14495989 | 0.78 | CYP2C9 (0.36) | CYP2C9ALDH1A1LMNASMN1; SMN2NPSR1 | |
| SCHEMBL10331497 | 0.78 | CYP2C9 (0.36) | CYP2C9ALDH1A1LMNASMN1; SMN2NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240239930-A1 | FUNCTIONALIZED MALEIC ACID COPOLYMERS FOR ENHANCED BIOACTIVITY | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2024-07-18 | — | — | US | disclosed |
| US-20230399493-A1 | FLAME-RETARDANT RESIN COMPOSITION, FLAME-RETARDANT RESIN MOLDED PRODUCT, FLAME-RETARDANT RESIN HOUSING, AND ELECTRONIC DEVICE | Konica Minolta, Inc. (JP) | 2023-12-14 | — | — | US | disclosed |
| US-20230312947-A1 | DISPERSING AGENT, DISPERSION ELEMENT, INK COMPOSITION, AND METHOD FOR MANUFACTURING SAME | NISSIN CHEMICAL INDUSTRY CO., LTD. (JP) | 2023-10-05 | — | — | US | disclosed |
| US-20230303745-A1 | COMPOSITION AND METHOD FOR PROVIDING WATER-REPELLENCY | HEIQ PTY LTD (AU) | 2023-09-28 | — | — | US | disclosed |
| US-20230303745-A1 | COMPOSITION AND METHOD FOR PROVIDING WATER-REPELLENCY | HEIQ PTY LTD (AU) | 2023-09-28 | — | — | US | disclosed |
| US-20180208695-A1 | UV-ABSORBING POLYMERS AND FORMULATIONS THEREOF | ISP INVESTMENTS LLC (US) | 2018-07-26 | — | — | US | disclosed |
| US-10023751-B2 | Anti-smudge and anti-graffiti compositions | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 2018-07-17 | — | — | US | disclosed |
| US-9920152-B2 | UV-absorbing polymers and formulations thereof | ISP INVESTMENTS LLC (US) | 2018-03-20 | — | — | US | disclosed |
| US-20170322436-A1 | POLYMERIZABLE COMPOSITION, WAVELENGTH CONVERSION MEMBER, BACKLIGHT UNIT, AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2017-11-09 | — | — | US | disclosed |
| US-20170114173-A1 | UV-ABSORBING POLYMERS AND FORMULATIONS THEREOF | ISP INVESTMENTS LLC (US) | 2017-04-27 | — | — | US | disclosed |
| US-20100222453-A1 | METHOD FOR COLORING BUILDING MATERIALS USING A CATIONIC PIGMENT DISPERSION | SUN CHEMICAL CORPORATION (US) | 2010-09-02 | — | — | US | disclosed |
| US-20100189661-A1 | POLYMER-BOUND UV ABSORBERS IN PERSONAL CARE COMPOSITIONS | PHARMACHEM LABORATORIES LLC | 2010-07-29 | — | — | US | disclosed |
| US-20090246513-A1 | Process for Producing Anti-Fog Coating | UNIVERSITé LAVAL (CA) | 2009-10-01 | — | — | US | disclosed |
| US-20090226395-A1 | Pharmaceutical compositions of beta-lapachone and beta-lapachone analogs with improved tumor targeting potential | ARQULE, INC. (US) | 2009-09-10 | — | — | US | disclosed |
| US-20090148777-A1 | Room temperature crosslinkable ion conductive polymer system | CIBA CORP. | 2009-06-11 | — | — | US | disclosed |
| US-20090098645-A1 | Cell culture article and methods thereof | CORNING INCORPORATED | 2009-04-16 | — | — | US | disclosed |
| US-20090025874-A1 | Novel Adducts Useful As Cure Components For Anaerobic Curable Compositions | HENKEL CORPORATION (US) | 2009-01-29 | — | — | US | disclosed |
| US-7282263-B2 | In presence of maleinimide-styrene quaternized polymer as dispersion agent | SUN CHEMICAL CORPORATION (US) | 2007-10-16 | — | — | US | disclosed |
| US-20070093610-A1 | Method for preparing styrene and maleimide copolymer using super critical fluid | LG CHEM, LTD. (KR) | 2007-04-26 | — | — | US | disclosed |
| US-7202304-B2 | Anhydride polymers for use as curing agents in epoxy resin-based underfill material | INTEL CORPORATION (US) | 2007-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170114173-A1 | UV-ABSORBING POLYMERS AND FORMULATIONS THEREOF | PUF60, UACA, UMPS | CYP2C9 1333/4885ALDH1A1 511/4885LMNA 1645/4885 |
| US-20180208695-A1 | UV-ABSORBING POLYMERS AND FORMULATIONS THEREOF | PUF60, UACA, UMPS | CYP2C9 1333/4885ALDH1A1 511/4885LMNA 1645/4885 |
| US-20100189661-A1 | POLYMER-BOUND UV ABSORBERS IN PERSONAL CARE COMPOSITIONS | CUTA, UACA, LAGE3 | CYP2C9 2617/4885ALDH1A1 605/4885LMNA 33/4885 |
| US-20240239930-A1 | FUNCTIONALIZED MALEIC ACID COPOLYMERS FOR ENHANCED BIOACTIVITY | MDH2, ME1, DDAH1 | CYP2C9 1989/4885ALDH1A1 584/4885LMNA 2445/4885 |
| US-20090226395-A1 | Pharmaceutical compositions of beta-lapachone and beta-lapachone analogs with improved tumor targeting potential | NQO1, KEAP1, DLD | CYP2C9 1651/4885ALDH1A1 929/4885LMNA 44/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.